{"entity":{"type":"insider","cik":"0001794284","url":"/insider/0001794284","json_url":"/insider/0001794284.json","name":"Scott Kathleen D.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2022-12-01","last":"2026-06-16","span_basis":"filed_date"},"name_variants":[{"name":"Scott Kathleen D.","source":"filing","n_filings":6,"first_seen":"2022-12-01","last_seen":"2026-06-16"}],"transactions":[{"id":5961116,"accession":"0001493152-26-028884","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-26-028884","line_url":"/filing/0001493152-26-028884#line-1","is_derivative":false,"issuer_cik":"0001794284","issuer_name":"Dermata Therapeutics, Inc.","issuer_ticker":"DRMA","issuer_name_source":null,"issuer_url":"/issuer/0001794284","owner_cik":"0001794284","owner_name":"Scott Kathleen D.","owner_display_name":"Scott Kathleen D.","owner_url":"/insider/0001794284","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11.0,"shares_display":"11","price_per_share":1.1901,"price_display":"1.19","price_state":"stated","total_value":13.0911,"total_display":"13.09","total_whole":"13","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-16","filed_date":"2026-06-16","scope":"insider"},{"id":5125672,"accession":"0001415889-25-022760","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-022760","line_url":"/filing/0001415889-25-022760#line-2","is_derivative":false,"issuer_cik":"0001671858","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001671858","owner_cik":"0001794284","owner_name":"Scott Kathleen D.","owner_display_name":"Scott Kathleen D.","owner_url":"/insider/0001794284","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":187500.0,"total_display":"187,500.00","total_whole":"187,500","shares_owned_after":10042.0,"shares_owned_after_display":"10,042","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-21","filed_date":"2025-08-22","scope":"insider"},{"id":4146519,"accession":"0001415889-25-014184","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-014184","line_url":"/filing/0001415889-25-014184#line-2","is_derivative":false,"issuer_cik":"0001671858","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001671858","owner_cik":"0001794284","owner_name":"Scott Kathleen D.","owner_display_name":"Scott Kathleen D.","owner_url":"/insider/0001794284","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":14.1033,"price_display":"14.10","price_state":"stated","total_value":705165.0,"total_display":"705,165.00","total_whole":"705,165","shares_owned_after":7424.0,"shares_owned_after_display":"7,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-20","filed_date":"2025-05-22","scope":"insider"},{"id":3178722,"accession":"0001415889-24-025370","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-025370","line_url":"/filing/0001415889-24-025370#line-2","is_derivative":false,"issuer_cik":"0001671858","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001671858","owner_cik":"0001794284","owner_name":"Scott Kathleen D.","owner_display_name":"Scott Kathleen D.","owner_url":"/insider/0001794284","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":200000.0,"total_display":"200,000.00","total_whole":"200,000","shares_owned_after":4949.0,"shares_owned_after_display":"4,949","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-16","filed_date":"2024-10-17","scope":"insider"},{"id":2485895,"accession":"0001415889-24-021882","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-021882","line_url":"/filing/0001415889-24-021882#line-2","is_derivative":false,"issuer_cik":"0001671858","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001671858","owner_cik":"0001794284","owner_name":"Scott Kathleen D.","owner_display_name":"Scott Kathleen D.","owner_url":"/insider/0001794284","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":200000.0,"total_display":"200,000.00","total_whole":"200,000","shares_owned_after":13199.0,"shares_owned_after_display":"13,199","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-20","filed_date":"2024-08-21","scope":"insider"},{"id":6575104,"accession":"0001209191-22-059187","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-059187","line_url":"/filing/0001209191-22-059187#line-1","is_derivative":false,"issuer_cik":"0001671858","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001671858","owner_cik":"0001794284","owner_name":"Scott Kathleen D.","owner_display_name":"Scott Kathleen D.","owner_url":"/insider/0001794284","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8250.0,"shares_display":"8,250","price_per_share":6.2432,"price_display":"6.24","price_state":"stated","total_value":51506.4,"total_display":"51,506.40","total_whole":"51,506","shares_owned_after":8250.0,"shares_owned_after_display":"8,250","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-29","filed_date":"2022-12-01","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001853816","name":"Dermata Therapeutics, Inc.","url":"/issuer/0001853816","role":"Director","n_filings":1,"first_seen":"2026-06-16","last_seen":"2026-06-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001671858","name":"ARS Pharmaceuticals, Inc.","url":"/issuer/0001671858","role":"Officer (Chief Financial Officer)","n_filings":5,"first_seen":"2022-12-01","last_seen":"2025-08-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001794284","retrieved_at":"2026-08-22T13:12:17+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}